10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The treatment of neuroinfectious diseases depends on the underlying cause and may involve antimicrobial agents, antiviral medications, or antifungal drugs. In Bacterial Meningitis, prompt administration of antibiotics is crucial to prevent severe complications such as brain damage or death. Antiviral Drugs play a key role in managing viral encephalitis, while antiparasitic and antifungal medications are employed for infections like cerebral toxoplasmosis or fungal meningitis. Complications of neuroinfectious diseases can be severe and may include long-term neurological sequelae, cognitive impairment, and, in some cases, chronic disability. Rehabilitation and supportive care are often integral components of managing complications and optimizing patient outcomes. Prevention strategies for neuroinfectious diseases include vaccination against specific pathogens known to cause these infections, such as the meningococcal vaccine, the Japanese encephalitis vaccine, or the varicella-zoster vaccine. Additionally, practicing good hygiene, avoiding exposure to vectors in endemic regions, and implementing public health measures contribute to preventing the spread of neuroinfectious diseases. Ongoing research in neuroinfectious diseases focuses on understanding the pathogenesis of these infections, developing novel diagnostic tools, and exploring innovative treatment approaches. The interdisciplinary collaboration between neurologists, infectious disease specialists, microbiologists, and public health experts is essential for advancing our knowledge and improving the management and prevention of neuroinfectious diseases.
By signing up, you agree to join our mailing list to receive information and updates.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : The impact of expanded adolescent vaccination against Omicron waves depends on the epidemic status: A mathematical modelling study
Anna Fairweather, University of Oxford, United Kingdom
Title : Comprehensive HIV care through integrated STI and primary care services at the LGBTQ+ Center of Southern Nevada
Darya V Fridman, The Southern Nevada LGBTQ+ Center, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Meeting the needs of adults aged 50+ with HIV through the new opening of a primary care clinic at the LGBTQ Center of Southern Nevada
Darya V Fridman, The Southern Nevada LGBTQ+ Center, United States
Title : Common infections in cancer patients – narrative review and clinical pearls
Patricia Tai, University of Saskatchewan, Canada